Acute interstitial pneumonitis

Acute interstitial pneumonitis
Hyaline membranes in acute interstitial pneumonitis
Synonyms	Hamman–Rich syndrome
Pronounce	N/A
Specialty	Pulmonology
Symptoms	Cough, dyspnea, fever
Complications	Respiratory failure, acute respiratory distress syndrome
Onset	Sudden
Duration	Days to weeks
Types	N/A
Causes	Unknown, possibly viral infection or autoimmune disease
Risks	Smoking, viral infections, autoimmune disorders
Diagnosis	Chest X-ray, CT scan, lung biopsy
Differential diagnosis	Acute respiratory distress syndrome, pneumonia, pulmonary embolism
Prevention	N/A
Treatment	Supportive care, mechanical ventilation, corticosteroids
Medication	N/A
Prognosis	Poor, high mortality rate
Frequency	Rare
Deaths	N/A

File:CRIM.PULMONOLOGY2012-678249.001.jpg

Histopathological image of acute interstitial pneumonitis

Acute interstitial pneumonitis (AIP), also known as Hamman-Rich syndrome, is a rare and severe form of interstitial lung disease characterized by the rapid onset of respiratory failure. It is classified as an idiopathic form of diffuse alveolar damage (DAD) and is considered a type of acute respiratory distress syndrome (ARDS).

Pathophysiology

AIP is characterized by diffuse alveolar damage, which involves injury to the alveolar epithelium and capillary endothelium. This leads to the formation of hyaline membranes, interstitial edema, and infiltration of inflammatory cells. The exact cause of AIP is unknown, but it is thought to be triggered by an acute inflammatory response in the lungs.

Clinical presentation

Patients with AIP typically present with sudden onset of dyspnea, cough, and fever. The condition progresses rapidly to severe respiratory failure, often requiring mechanical ventilation. The clinical course is similar to that of ARDS, but AIP is distinguished by its idiopathic nature and histological findings.

Diagnosis

The diagnosis of AIP is based on clinical presentation, imaging studies, and histopathological examination. High-resolution computed tomography (HRCT) of the chest often shows diffuse bilateral ground-glass opacities and consolidation. A lung biopsy is usually required to confirm the diagnosis, revealing the characteristic diffuse alveolar damage with hyaline membrane formation.

Treatment

There is no specific treatment for AIP, and management is primarily supportive. Patients often require mechanical ventilation and intensive care. Corticosteroids and other immunosuppressive agents may be used, but their efficacy is uncertain. The prognosis is generally poor, with a high mortality rate.

Prognosis

The prognosis of AIP is poor, with a high mortality rate, often exceeding 50%. Survivors may experience long-term pulmonary sequelae, including pulmonary fibrosis.

Related pages

• Interstitial lung disease
• Acute respiratory distress syndrome
• Diffuse alveolar damage
• Pulmonary fibrosis

Gallery

• Histopathological image showing diffuse alveolar damage
  Histopathological image showing diffuse alveolar damage
• Another view of diffuse alveolar damage in AIP
  Another view of diffuse alveolar damage in AIP
• Diffuse alveolar damage with hyaline membranes
  Diffuse alveolar damage with hyaline membranes